Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by DexCom, Inc.

< Previous 1 2 3 Next >
Dexcom and ŌURA Announce Strategic Partnership
From DexCom, Inc.
Via Business Wire
Tickers DXCM
Dexcom Helps People With Diabetes Take the First Step to Discover What They’re Made Of on World Diabetes Day
From DexCom, Inc.
Via Business Wire
Tickers DXCM
Dexcom Reports Third Quarter 2024 Financial Results
From DexCom, Inc.
Via Business Wire
Tickers DXCM
Dexcom Schedules Third Quarter 2024 Earnings Release and Conference Call for October 24, 2024 at 4:30 p.m. Eastern Time.
From DexCom, Inc.
Via Business Wire
Tickers DXCM
Dexcom, Beyond Type 2 and Retta Establish National Glucose Awareness Week to Close the Glucose Knowledge Gap
From DexCom, Inc.
Via Business Wire
Tickers DXCM
Dexcom Brings Mentorship to Centerfield, Welcomes New, Star Athletes to Its Ground-breaking NIL Program Dexcom U
From Dexcom, Inc.
Via Business Wire
Tickers DXCM
Dexcom CGM Worn in Outer Space as Part of First-of-its-Kind Polaris Dawn Mission
From DexCom, Inc.
Via Business Wire
Tickers DXCM
Dexcom to Showcase Transformational Impact of Dexcom CGM Technology at the EASD 2024 Conference Symposium
From DexCom, Inc.
Via Business Wire
Tickers DXCM
Dexcom Announces Upcoming Conference Presentation
From DexCom, Inc.
Via Business Wire
Tickers DXCM
Stelo by Dexcom, the First Over-the-Counter Glucose Biosensor in the U.S., Is Now Available
From DexCom, Inc.
Via Business Wire
Tickers DXCM
Dexcom Reports Second Quarter 2024 Financial Results, Updates Guidance, and Announces $750 Million Share Repurchase Program
From DexCom, Inc.
Via Business Wire
Tickers DXCM
Dexcom Schedules Second Quarter 2024 Earnings Release and Conference Call for July 25, 2024 at 4:30 p.m. Eastern Time.
From DexCom, Inc.
Via Business Wire
Tickers DXCM
Dexcom Showcases Extensive Clinical Data at ADA 2024 Demonstrating the Benefit of Dexcom CGM Use Among People With Type 2 Diabetes
From DexCom, Inc.
Via Business Wire
Tickers DXCM
Dexcom G7 Now Connects Directly to Apple Watch in the U.S.
From DexCom, Inc.
Via Business Wire
Tickers DXCM
Nova Scotia Now Providing Coverage for Dexcom Continuous Glucose Monitoring Systems
From Dexcom, Inc.
Via Business Wire
Tickers DXCM
Dexcom Announces Upcoming Conference Presentation
From DexCom, Inc.
Via Business Wire
Tickers DXCM
Dexcom Reports First Quarter 2024 Financial Results
From DexCom, Inc.
Via Business Wire
Tickers DXCM
Dexcom Publishes Annual Sustainability Report
From DexCom, Inc.
Via Business Wire
Tickers DXCM
Dexcom Schedules First Quarter 2024 Earnings Release and Conference Call for April 25, 2024 at 4:30 p.m. Eastern Time
From DexCom, Inc.
Via Business Wire
Tickers DXCM
Stelo by Dexcom First Glucose Biosensor to be Cleared by FDA as Over-the-Counter
From DexCom, Inc.
Via Business Wire
Tickers DXCM
Dexcom Announces Upcoming Conference Presentation
From DexCom, Inc.
Via Business Wire
Tickers DXCM
Dexcom Reports Fourth Quarter and Fiscal Year 2023 Financial Results
From DexCom, Inc.
Via Business Wire
Tickers DXCM
Dexcom Schedules Fourth Quarter and Fiscal Year 2023 Earnings Release and Conference Call for February 8, 2024 at 4:30 p.m. Eastern Time
From DexCom, Inc.
Via Business Wire
Tickers DXCM
Dexcom Reports Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2023 and Initial 2024 Outlook
From DexCom, Inc.
Via Business Wire
Tickers DXCM
Dexcom to Present at 42nd Annual J.P. Morgan Healthcare Conference
From DexCom, Inc.
Via Business Wire
Tickers DXCM
Dexcom G7 is Now the Most Accurate, Smallest, Easy-to-Use CGM Connected to the Tandem t:slim X2 Insulin Pump
From DexCom, Inc.
Via Business Wire
Tickers DXCM
Dexcom Announces Upcoming Conference Presentation
From DexCom, Inc.
Via Business Wire
Tickers DXCM
Dexcom Unveils Portrait Gallery to Portray Emotional Highs and Lows of Living With Diabetes on World Diabetes Day
From DexCom, Inc.
Via Business Wire
Tickers DXCM
Dexcom Reports Third Quarter 2023 Financial Results, Raises 2023 Revenue and Margin Guidance, and Announces $500 Million Share Repurchase Program
From DexCom, Inc.
Via Business Wire
Tickers DXCM
Dexcom Solidifies Global Leadership in Continuous Glucose Monitoring With New Clinical Data Presented at EASD
From DexCom, Inc.
Via Business Wire
Tickers DXCM
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.